Funding · Biotech
PorMedTec raises approximately ¥1.01bn for transplant development
The financing supports clinical application of genetically modified donor-pig kidneys.
Named backers include Tokushukai Medical Group, Hiroshi Nagashima, Genjiro Miwa and Iichiro Amano.
PorMedTec is preparing Japanese kidney-transplant studies with Hokkaido University Hospital and Shonan Kamakura General Hospital, targeting a 2028 start.
The company is producing donor pigs for those studies, with surgeons practicing retrieval and transplantation. The clinical program is planned rather than an already established human treatment.
Use of funds
Develop clinical application of xenotransplantation, including genetically modified donor-pig kidneys
Funding history
Funding · This round¥1B